Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selnoflast in moderate to severe asthma
NL-OMON59879Phase 1Completed
- Sponsor
- Roche
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of selnoflast in asthma, sponsored by Roche. Primary endpoint: Primary endpoint(s). Started Mar 2024; status: completed.
02
Drugs
selnoflast
03
Conditions
asthma
Beyond the preview
Go deeper on NL-OMON59879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59879.